We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBDC icon
1001
Blue Owl Capital
OBDC
$5.74B
$204K ﹤0.01%
14,250
-1,000
-7% -$14.2K
QLV icon
1002
FlexShares US Quality Low Volatility Index Fund
QLV
$167M
$204K ﹤0.01%
3,000
+214
+8% +$14K
IGIB icon
1003
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$204K ﹤0.01%
3,832
+797
+26% +$41.6K
GDS icon
1004
GDS Holdings
GDS
$6.41B
$204K ﹤0.01%
6,659
-86
-1% -$2.18K
CNI icon
1005
Canadian National Railway
CNI
$76.6B
$204K ﹤0.01%
1,956
+607
+45% +$61.8K
HODL icon
1006
VanEck Bitcoin Trust
HODL
$1.08B
$203K ﹤0.01%
6,650
+775
+13% +$21.6K
ELS icon
1007
Equity Lifestyle Properties
ELS
$12.6B
$202K ﹤0.01%
3,270
+1,204
+58% +$76.8K
USTB icon
1008
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.4B
$202K ﹤0.01%
+3,966
New +$200K
NBIX icon
1009
Neurocrine Biosciences
NBIX
$16.6B
$200K ﹤0.01%
1,591
+212
+15% +$24.3K
HAL icon
1010
Halliburton
HAL
$26.6B
$200K ﹤0.01%
9,805
-2,511
-20% -$52.7K
NTRS icon
1011
Northern Trust
NTRS
$33.9B
$199K ﹤0.01%
1,572
-201
-11% -$20.6K
FSV icon
1012
FirstService
FSV
$6.32B
$199K ﹤0.01%
1,141
-16
-1% -$2.77K
NTNX icon
1013
Nutanix
NTNX
$16.9B
$199K ﹤0.01%
2,606
+1,281
+97% +$92.2K
CRON
1014
Cronos Group
CRON
$1.14B
$199K ﹤0.01%
104,001
+1
+0% +$2
TEF
1015
DELISTED
Telefonica
TEF
$198K ﹤0.01%
37,949
-586
-2% -$2.94K
SNX icon
1016
TD Synnex
SNX
$20.2B
$198K ﹤0.01%
1,458
-288
-16% -$33.8K
PEGA icon
1017
Pegasystems
PEGA
$5.38B
$198K ﹤0.01%
3,656
+1,688
+86% +$76.5K
ALGN icon
1018
Align Technology
ALGN
$12.3B
$198K ﹤0.01%
1,044
+415
+66% +$73.3K
INSM icon
1019
Insmed
INSM
$28.6B
$198K ﹤0.01%
1,964
+27
+1% +$2.06K
AMG icon
1020
Affiliated Managers Group
AMG
$9.76B
$196K ﹤0.01%
998
-172
-15% -$29.8K
MPT
1021
Medical Properties Trust
MPT
$2.81B
$196K ﹤0.01%
45,477
+4,118
+10% +$20.4K
KNX icon
1022
Knight Transportation
KNX
$11.4B
$196K ﹤0.01%
4,430
+2,048
+86% +$87.1K
SHYG icon
1023
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
$195K ﹤0.01%
4,530
+2,600
+135% +$110K
RF icon
1024
Regions Financial
RF
$26.8B
$195K ﹤0.01%
8,296
+2,908
+54% +$61.6K
GL icon
1025
Globe Life
GL
$14.3B
$195K ﹤0.01%
1,566
+13
+0.8% +$1.58K

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.